Nutrition

L-Theanine

/ɛl ˈθiːənɪn/

Definition

L-Theanine is a non-protein amino acid found almost exclusively in tea leaves (Camellia sinensis) that crosses the blood-brain barrier and elevates alpha-band brain oscillatory activity, producing relaxed alertness without sedation. By inhibiting glutamate reuptake and raising GABA and serotonin levels, it delivers a calm-focus state that sets it apart from conventional stimulants.

Unlike sedatives, L-Theanine does not impair alertness or induce drowsiness; its anxiolytic effect operates through neuromodulation rather than CNS depression.

How it works

L-Theanine reaches the brain within 30-40 minutes of ingestion, transported across the blood-brain barrier via the leucine-preferring amino acid transport system 2. Once inside, it acts on the glutamatergic system by blocking reuptake at NMDA, AMPA, and kainate receptors, reducing excitatory signalling while indirectly boosting synthesis of GABA and serotonin 2. The effect is measurable at doses as low as 50 mg: electroencephalography reveals increased alpha-band oscillatory activity (8-14 Hz) in occipital and parietal regions, the neurophysiological signature of relaxed, receptive attention 2.

Beyond neuromodulation, L-Theanine measurably dampens the sympathetic nervous system's response to acute psychological stress. Kimura and colleagues demonstrated that 200 mg attenuated both heart rate acceleration and the decline in salivary immunoglobulin A that accompanies stress exposure, indicating a blunted adrenergic reaction without any impairment of task performance 1. Think of the effect as a volume knob on the threat-response circuit: turning noise down without switching off the signal.

In its natural form, L-Theanine co-occurs with caffeine in Camellia sinensis, with a typical cup of green tea providing 5-45 mg of the compound 2. Supplementation at 100-200 mg, typically paired with caffeine at a 2:1 theanine-to-caffeine ratio, moderates caffeine's anxiogenic and vasoconstrictive effects while preserving its stimulatory action 3. This pharmacological partnership explains why the same plant can produce both composed attention and elevated drive.

~15 ms
faster visual reaction time vs placebo across five RCTs
Mátyus et al. (2025) 4

In action

Example

A knowledge worker preparing for a high-stakes client presentation takes 200 mg of L-Theanine alongside a 100 mg caffeine tablet an hour before the session. The caffeine sharpens drive; the theanine suppresses the accompanying tension. By the time the session begins, attention is focused without the jitteriness that caffeine alone would have produced, and composure under questioning holds.

This is the theanine-caffeine stack in practice: each compound contributing what the other cannot.

Why it matters

The practical case for L-Theanine rests on two converging lines of evidence. A systematic review of nine randomised controlled trials found that doses of 200-400 mg per day reduced subjective stress and anxiety in participants exposed to acute stressors, with a safety profile matching placebo at doses up to 500 mg per day 3. For performers who depend on sustained attention under pressure, this is a meaningful property: an anxiolytic effect without the sedation that would undermine cognitive output.

The cognitive-performance evidence is promising, though more selective than popular accounts suggest. A 2025 meta-analysis of five RCTs detected dose-dependent improvements in visual information processing speed (approximately 15 ms faster than placebo), but found no significant effect on simple reaction time or Stroop interference performance 4. The benefits are real; they are confined to specific perceptual-speed tasks rather than general cognitive enhancement. For practitioners, this positions L-Theanine as a stress buffer and perceptual-speed aid, not a broad nootropic.

Frequently asked
What does L-Theanine do to the brain?+

L-Theanine crosses the blood-brain barrier and increases alpha-band oscillatory activity in the brain, the electrical pattern associated with relaxed wakefulness. It reduces excitatory glutamate signalling at NMDA and AMPA receptors and raises levels of GABA and serotonin, producing calm alertness without sedation within 30-40 minutes of ingestion.

Does L-Theanine reduce anxiety?+

At doses of 200-400 mg per day, L-Theanine reduced subjective stress and anxiety across nine randomised controlled trials reviewed in a 2020 systematic review, with a safety profile matching placebo up to 500 mg per day. The effect is most pronounced in response to acute stressors rather than chronic anxiety disorders.

How much L-Theanine should I take?+

For stress management and focused work, 100-200 mg per dose is the most commonly studied range and the standard for the theanine-caffeine stack (paired at a 2:1 ratio with caffeine). Controlled trials support safety at up to 500 mg per day. Optimal timing is 30-60 minutes before the target period.

Does L-Theanine actually improve focus and cognitive performance?+

The evidence is selective rather than sweeping. A 2025 meta-analysis found L-Theanine produced approximately 15 ms faster visual reaction times compared to placebo, but no significant effect on simple reaction time or Stroop performance. The clearest benefit is attenuated stress response during cognitively demanding tasks, not general intelligence enhancement.

Explore more
Free download

The 90-Day Kickstarter Protocol

Your day-by-day reset for sleep, stress & energy · PDF

Sources
1 Kimura et al. (2007) l-Theanine reduces psychological and physiological stress responses Biological Psychology DOI
2 Nobre et al. (2008) L-theanine, a natural constituent in tea, and its effect on mental state Asia Pacific Journal of Clinical Nutrition DOI
3 Williams et al. (2019) The Effects of Green Tea Amino Acid L-Theanine Consumption on the Ability to Manage Stress and Anxiety Levels: a Systematic Review Plant Foods for Human Nutrition DOI
4 Mátyus et al. (2025) Promising, but Not Completely Conclusive—The Effect of l-Theanine on Cognitive Performance Based on the Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Clinical Trials Journal of Clinical Medicine DOI